国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rubrobacter xylanophilus Carboxylate-amine ligase Rxyl_1350 (Rxyl_1350) CSB-YP624374RAAH
CSB-EP624374RAAH
CSB-BP624374RAAH
CSB-MP624374RAAH
CSB-EP624374RAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rubrobacter xylanophilus Glutamine amidotransferase subunit pdxT (pdxT) CSB-YP624375RAAH
CSB-EP624375RAAH
CSB-BP624375RAAH
CSB-MP624375RAAH
CSB-EP624375RAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rubrobacter xylanophilus 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase (hisA) CSB-YP624376RAAH
CSB-EP624376RAAH
CSB-BP624376RAAH
CSB-MP624376RAAH
CSB-EP624376RAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rubrobacter xylanophilus 50S ribosomal protein L9 (rplI) CSB-YP624377RAAH
CSB-EP624377RAAH
CSB-BP624377RAAH
CSB-MP624377RAAH
CSB-EP624377RAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rubrobacter xylanophilus Protein grpE (grpE) CSB-YP624378RAAH
CSB-EP624378RAAH
CSB-BP624378RAAH
CSB-MP624378RAAH
CSB-EP624378RAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rubrobacter xylanophilus Pyridoxamine kinase (pdxY) CSB-YP624379RAAH
CSB-EP624379RAAH
CSB-BP624379RAAH
CSB-MP624379RAAH
CSB-EP624379RAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rubrobacter xylanophilus DNA ligase (ligA), partial CSB-YP624380RAAH
CSB-EP624380RAAH
CSB-BP624380RAAH
CSB-MP624380RAAH
CSB-EP624380RAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. 4-hydroxy-2-oxovalerate aldolase 2 (Mmcs_5438) CSB-YP624381MLF
CSB-EP624381MLF
CSB-BP624381MLF
CSB-MP624381MLF
CSB-EP624381MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. UPF0061 protein Mmcs_5202 (Mmcs_5202) CSB-YP624382MLF
CSB-EP624382MLF
CSB-BP624382MLF
CSB-MP624382MLF
CSB-EP624382MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Putative regulator of ribonuclease activity (Mmcs_5056) CSB-YP624383MLF
CSB-EP624383MLF
CSB-BP624383MLF
CSB-MP624383MLF
CSB-EP624383MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Type III pantothenate kinase (coaX) CSB-YP624384MLF
CSB-EP624384MLF
CSB-BP624384MLF
CSB-MP624384MLF
CSB-EP624384MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Cysteine--tRNA ligase (cysS) CSB-YP624385MLF
CSB-EP624385MLF
CSB-BP624385MLF
CSB-MP624385MLF
CSB-EP624385MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Trehalose-phosphate synthase (otsA) CSB-YP624386MLF
CSB-EP624386MLF
CSB-BP624386MLF
CSB-MP624386MLF
CSB-EP624386MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Putative phosphoserine aminotransferase (serC) CSB-YP624387MLF
CSB-EP624387MLF
CSB-BP624387MLF
CSB-MP624387MLF
CSB-EP624387MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Response regulator mprA (mprA) CSB-YP624388MLF
CSB-EP624388MLF
CSB-BP624388MLF
CSB-MP624388MLF
CSB-EP624388MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. R2-like ligand binding oxidase (Mmcs_4214) CSB-YP624389MLF
CSB-EP624389MLF
CSB-BP624389MLF
CSB-MP624389MLF
CSB-EP624389MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. 2-oxoglutarate decarboxylase (kgd), partial CSB-YP624390MLF
CSB-EP624390MLF
CSB-BP624390MLF
CSB-MP624390MLF
CSB-EP624390MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Peptide chain release factor 1 (prfA) CSB-YP624391MLF
CSB-EP624391MLF
CSB-BP624391MLF
CSB-MP624391MLF
CSB-EP624391MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. Virginiamycin B lyase (vgb) CSB-YP624392MLF
CSB-EP624392MLF
CSB-BP624392MLF
CSB-MP624392MLF
CSB-EP624392MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycobacterium sp. 50S ribosomal protein L27 (rpmA) CSB-YP624393MLF
CSB-EP624393MLF
CSB-BP624393MLF
CSB-MP624393MLF
CSB-EP624393MLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>